Covered recipient · General Payments record
FLOYD KEITH UNDERHILL JR.
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,665.49
- Reported across 231 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $587.64 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $145.39 | 8 |
| Lilly USA, LLC | $58.49 | 4 |
| Philips Electronics North America Corporation | $53.39 | 1 |
| INOGEN, INC. | $37.96 | 3 |
| Abbott Laboratories | $34.69 | 2 |
| Novo Nordisk AS | $30.98 | 2 |
| PFIZER INC. | $30.67 | 2 |
| Amgen Inc. | $28.80 | 2 |
| Esperion Therapeutics, Inc. | $26.79 | 2 |
| Medtronic, Inc. | $25.49 | 1 |
| Acerta Pharma LLC | $24.70 | 1 |
| Astellas Pharma US Inc | $17.89 | 1 |
| GlaxoSmithKline, LLC. | $15.96 | 1 |
| ABIOMED | $15.05 | 1 |
| Merck Sharp & Dohme Corporation | $14.09 | 1 |
| Exact Sciences Corporation | $13.90 | 1 |
| Azurity Pharmaceuticals, Inc. | $13.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.99 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124895120 | CMS |
| Abbott Laboratories | $17.70 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124895118 | CMS |
| ABBVIE INC. | $20.37 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106259664 | CMS |
| ABBVIE INC. | $18.17 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106259666 | CMS |
| ABBVIE INC. | $9.65 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106259668 | CMS |
| ABBVIE INC. | $7.94 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106259670 | CMS |
| ABBVIE INC. | $34.16 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106259672 | CMS |
| ABBVIE INC. | $22.87 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106259674 | CMS |
| ABBVIE INC. | $24.22 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106259676 | CMS |
| ABBVIE INC. | $8.01 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106259678 | CMS |
| ABIOMED | $15.05 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142285069 | CMS |
| Amgen Inc. | $15.23 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111729989 | CMS |
| Amgen Inc. | $13.57 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111729991 | CMS |
| Astellas Pharma US Inc | $17.89 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139270214 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.70 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104663267 | CMS |
| Azurity Pharmaceuticals, Inc. | $13.40 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134013737 | CMS |
| Esperion Therapeutics, Inc. | $13.12 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129458534 | CMS |
| Esperion Therapeutics, Inc. | $13.67 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129458536 | CMS |
| Exact Sciences Corporation | $13.90 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114937600 | CMS |
| GlaxoSmithKline, LLC. | $15.96 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116674474 | CMS |
| INOGEN, INC. | $18.00 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144989621 | CMS |
| INOGEN, INC. | $8.47 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144989623 | CMS |
| INOGEN, INC. | $11.49 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144989625 | CMS |
| Lilly USA, LLC | $14.62 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134975212 | CMS |
| Lilly USA, LLC | $16.36 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134965939 | CMS |
| Lilly USA, LLC | $13.87 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134965941 | CMS |
| Lilly USA, LLC | $13.64 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134970997 | CMS |
| Medtronic, Inc. | $25.49 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117105741 | CMS |
| Merck Sharp & Dohme LLC | $14.09 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141935789 | CMS |
| Novo Nordisk Inc | $16.46 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096589776 | CMS |
| Novo Nordisk Inc | $14.52 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096706920 | CMS |
| PFIZER INC. | $14.44 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131049136 | CMS |
| PFIZER INC. | $16.23 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131966265 | CMS |
| Philips North America LLC | $53.39 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146864290 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.